Burrow vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 28)

Burrow

EmergingHome Improvement & Furniture

Furniture

DTC modular sofa brand with tool-free assembly for frequent movers; USB armrests and apartment-sized configurations competing with Article and Floyd for urban millennial furniture buyers.

AI VisibilityBeta
Overall Score
D28
Category Rank
#7 of 8
AI Consensus
64%
Trend
stable
Per Platform
ChatGPT
33
Perplexity
32
Gemini
20

About

Burrow is a direct-to-consumer furniture company specializing in modular, easy-to-assemble sofas and sectionals designed for apartment living and frequent movers — offering customizable configurations, premium fabric options, and tool-free assembly that allows buyers to reconfigure their sofa as their living space changes. Founded in 2017 by Stephen Kuhl and Kabeer Chopra in New York City, Burrow has raised approximately $67 million and targets urban millennials and Gen Z consumers who need quality furniture that can be configured to fit apartment layouts and disassembled for moves.\n\nBurrow's modular system uses hidden snap connectors that allow sofa components to connect and disconnect without tools — a two-person sofa can be disassembled into two armchair sections for a studio apartment, then reassembled as a larger sectional in a bigger space. The armrests include USB charging ports and can-holders, and the furniture ships in boxes via UPS (avoiding white-glove delivery scheduling fees). The design aesthetic is clean and modern, positioned between entry-level furniture (IKEA) and expensive designer brands.\n\nIn 2025, Burrow competes with Article (another DTC modern furniture brand), Floyd (minimalist modular furniture), IKEA (entry-level), and Crate & Barrel for modern sofa and living room furniture market share. The DTC furniture category saw significant growth during COVID (when home investment surged) followed by normalization as e-commerce furniture growth moderated. Burrow's 2025 strategy focuses on expanding its product line beyond sofas into more furniture categories (beds, dining, home office), growing its physical showroom presence to let customers experience the product before buying, and improving its sustainability credentials through material sourcing.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

28
Overall Score
90
#7
Category Rank
#9
64
AI Consensus
60
stable
Trend
stable
33
ChatGPT
99
32
Perplexity
99
20
Gemini
83
35
Claude
96
28
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.